Related Experiment Videos

Pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia diagnosed by PCR analysis

Yu Fujita1, Motoyasu Iikura1, Yuko Horio1

  • 1Department of Respiratory Medicine, National Centre for Global Health and Medicine, Tokyo, Japan.

Insights

This study details the first reported case of pulmonary Actinomyces graevenitzii infection mimicking organizing pneumonia. Molecular methods like PCR and gene sequencing were crucial for diagnosing this rare pulmonary actinomycosis.

Area of Science:

  • Medical Microbiology
  • Pulmonology
  • Infectious Diseases

Background:

  • Pulmonary actinomycosis is a rare bacterial infection.
  • Actinomyces graevenitzii is an infrequently identified species.
  • Organizing pneumonia is a distinct histopathological pattern of lung injury.

Observation:

  • A 69-year-old male presented with fever and night sweats, elevated inflammatory markers, and bilateral lung consolidations on imaging.
  • Lung biopsy showed organizing pneumonia with microabscesses, but initial cultures were negative.
  • Actinomyces graevenitzii was identified via PCR and 16S rRNA gene sequencing from the lung biopsy.

Findings:

  • This case represents the first documented instance of pulmonary Actinomyces graevenitzii infection presenting as organizing pneumonia.
  • Standard culture methods failed to identify the causative agent, highlighting limitations in diagnosing rare infections.
  • Molecular techniques, specifically PCR and 16S rRNA gene sequencing, proved essential for definitive diagnosis.

Implications:

  • Actinomycosis should be considered in the differential diagnosis of organizing pneumonia.
  • PCR and gene sequencing are valuable tools for diagnosing challenging cases of pulmonary actinomycosis.
  • Successful treatment involved a prolonged course of antibiotics, including ampicillin, amoxicillin, and clarithromycin.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...